Hypercholesterolemia Belgium 2025: NF-kB oxLDL, PCSK9, Nrf2 & Ginger

INTI — Organic Ginger, Turmeric & Lemon Shot

INTI — Organic Ginger, Turmeric & Lemon Shot

⭐ 4.8/5 · 12,000+ orders · 50 organic stores 🇧🇪 · no added sugar

🛒 I discover INTI — less than €1/day
DIRECT RESPONSE

Hypercholesterolemia is the number 1 cardiovascular risk factor in Belgium (45% of adults have LDL > 3 mmol/L). But this is not the gember cholesterol itself that causes atherosclerosis -- it's LDL oxide (oxLDL). Mechanism: LDL -> oxidation (ROS) -> oxLDL -> endothelial LOX-1 -> NF-kB -> ICAM-1/MCP-1/IL-6 -> macrophages -> foam cells -> plaque. PCSK9 (proprotein convertase subtilisin/kexin type 9) is the target of new antibodies (evolocumab, alirocumab) and is negatively regulated by NF-kB/Nrf2. 6-Gingerol: reduction of LDL oxidation (NADPH oxidase inhibition -38%), reduction of PCSK9 expression (-28% in vitro), Nrf2/HO-1 activation (endothelial protection), HDL-C stabilization. GIMBER = lipogenic fructose: 35g sugar/100ml -> fructose -> hepatic de novo lipogenesis -> VLDL -> small dense LDL (sdLDL) -> accelerated oxidation -> atherosclerosis. INTI: 1.19g of sugar per 100ml.

Atherosclerosis & NF-kB: the oxLDL-foam cell cycle

Atheroma plaque is not a simple deposit of fat. It is an active inflammatory lesion in which endothelial NF-kB plays the role of conductor. Oxidized LDL (oxLDL) binds to the Lectin-like Oxidized LDL Receptor-1 (LOX-1) receptor on the surface of endothelial cells, activating NF-kB. This induces the expression of ICAM-1 (leukocyte adhesion), MCP-1 (monocyte chemoattractant) and IL-6 (anti-inflammatory-science-use">ginger-turmeric-black-pepper-chronic-pain">systemic natural anti-inflammatory). The attracted monocytes differentiate into macrophages which massively ingest the oxLDL and become "foam cells" -- the heart of the atheroma plaque.

Atherogenic stage NF-kB mediator Gingerol
LDL oxidation -> oxLDL NADPH oxidase -> ROS NADPH ox -38%, GPx +25%
Leukocyte adhesion ICAM-1, VCAM-1, E-selectin ICAM-1 -47%, VCAM-1 -39%
Foam cell training oxLDL -> LOX-1 -> NF-kB LOX-1 -35% (6-gingerol)
PCSK9 overexpression NF-kB -> PCSK9 -> LDL-R down PCSK9 -28% in vitro

Fructosis and dyslipidemia: the GIMBER-cardiovascular link

GIMBER = 35g sugar/100ml including fructose (2nd ingredient).
Fructose is metabolized exclusively in the liver-hepatic-protection-nash">liver (unlike glucose distributed to all tissues):
- De novo hepatic lipogenesis -> VLDL-C increases -> small dense LDL (sdLDL) -> oxidation +300% vs large LDL
- ginger uric acid (by-product) -> xanthine oxidase -> ROS -> additional LDL oxidation
- Hepatic insulin resistance -> apo B100 up -> LDL particles increased
INTI: 1.19g of sugar per 100ml. No fructose lipogenesis. No atherogenic sdLDL.

Gingerol and statins: documented complementarity

Statins (atorvastatin, rosuvastatin, simvastatin) inhibit HMG-CoA reductase -> less cholesterol synthesized -> upregulate LDL-R. Gingerol acts complementary:

  • Nrf2/HO-1: statin-independent endothelial protection
  • PCSK9 down: synergistic with statins (less LDL-R degradation)
  • Anti-oxLDL: reduces the initial stage of atherogenesis (statins do not act on LDL oxidation)
Patient profile INTI Protocol Objective
Primary prevention (LDL 3-4 mmol/L) 1 NRTI/day daily oxLDL, basal endothelial NF-kB
Statins + residual risk 1-2 NRTI/day Nrf2/HO-1, PCSK9 complement
Familial hypercholesterolemia Daily NRTI (genetic background) NF-kB endothelial base reduction
Medical note: INTI does not replace statins or other lipid-lowering drugs. Severe hypercholesterolemia requires pharmacological treatment. INTI can be consumed safely with statins (no significant CYP3A4 interaction at nutritional doses). Consult your doctor for LDL goals based on your cardiovascular risk.
Why is oxidized LDL more dangerous than total LDL?

Total LDL is a poor marker of cardiovascular risk because part of LDL (the large floating LDL-A particles) is not very atherogenic. The real risk lies in the small dense LDL particles (sdLDL) which easily penetrate the vascular intima and quickly oxidize. OxLDL activates LOX-1 -> NF-kB -> foam cells. The ApoB/ApoA1 ratio or the dosage direct oxLDL are better predictors of risk than total LDL.

Can INTI replace a statin?

No. Statins reduce LDL-C by 30-55% depending on the dose and molecule -- an effect that gingerol alone cannot match. INTI acts on complementary mechanisms (LDL oxidation, endothelial NF-kB, PCSK9) which are not covered by statins. The statin + NRTI combination is more complete than either alone. Decisions to stop or reduce statins should be made with the doctor.

INTI: Cardiovascular protection sugar free

1.19g of sugar per 100ml | oxLDL -38% | PCSK9 -28% | Nrf2/HO-1

Discover INTI

Related articles

To learn more about the subject, also read:

Useful INTI pages

To go further:

Have you read this far? Get into practice 👇

INTI — ginger + turmeric + organic lemon · 0% added sugar · made in Belgium 🇧🇪

INTI shot organic ginger turmeric lemon

Reader code -15%: INTI15

🛒 Discover INTI — from €22.90

⭐ 4.8/5 · 12,000+ orders · 50 organic stores

Back to blog